GH Research Ireland Ltd, a privately-held clinical-stage biopharmaceutical company, announced on Monday that it has completed a USD125m Series B financing.
The financing was co-led by RA Capital and RTW Investments and other new investors included Acuta Capital Partners, Boxer Capital, Cormorant Asset Management, Deerfield Management Company, Logos Capital, Surveyor Capital (a Citadel company), Venrock Healthcare Capital Partners and Verition Fund Management.
The exclusive placement agent for the offering is Cowen while legal advisor is Dentons Ireland.
TiumBio files Clinical Trial Application to start Phase 1b TU7710 study
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Scancell initiates SCOPE trial's iSCIB1+ cohort
Valneva launches Phase 1 trial for next-generation Zika vaccine
argenx obtains VYVGART approval for primary immune thrombocytopenia in Japan
Bio-Thera Solutions' BAT8006 phase II Study receives US FDA IND approval